{"raw_mentions": "For example, the IC50 that compound of Formula I of the present invention demonstrates\uff1c10 \u03bc M, preferred\uff1c1 \u03bc M.\nCompound (embodiment number)EGFR-dependency inhibition of proliferation IC\n                      <sub>50</sub>[nM]\n                    1 (trans-compound)??11 (1) (trans-compound)??11 (3) (trans-compound)??11 (5) (trans-compound)??1??(36)??1??(44)??1"}
{"final_json": [{"molecule_name": "compound of Formula I", "protein_target_name": null, "binding_metric": "IC50", "value": "<10", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "1 (trans-compound)", "protein_target_name": "EGFR", "binding_metric": "IC50", "value": "11", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "3 (trans-compound)", "protein_target_name": "EGFR", "binding_metric": "IC50", "value": "11", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "5 (trans-compound)", "protein_target_name": "EGFR", "binding_metric": "IC50", "value": "11", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "36", "protein_target_name": "EGFR", "binding_metric": "IC50", "value": "1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "44", "protein_target_name": "EGFR", "binding_metric": "IC50", "value": "1", "unit": "nM", "is_logarithmic": false}]}
